Besides B lymphocyte antigen CD19 [11,16,17], these include CD22 in ALL [19], CD20 in NHL [20], B cell maturation antigen (BCMA) in multiple myeloma [21], and CD30 in Hodgkin lymphoma [22]. This evidence concerns the gene TNFRSF17 and non-Hodgkin lymphoma.